<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T02:51:21Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/171689" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/171689</identifier><datestamp>2025-12-05T12:19:39Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478916</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Cancer: Limitations of therapies exposed</dc:title>
   <dc:creator>Casanovas i Casanovas, Oriol</dc:creator>
   <dc:subject>Angiogènesi</dc:subject>
   <dc:subject>Medicaments antineoplàstics</dc:subject>
   <dc:subject>Tumors</dc:subject>
   <dc:subject>Neovascularization</dc:subject>
   <dc:subject>Antineoplastic agents</dc:subject>
   <dcterms:abstract>Anti-angiogenic drugs, used for cancer treatment, target blood-vessel formation in tumours. Two studies commented here show that such drugs can reduce the efficiency of other anticancer agents and increase the aggressiveness of tumours.</dcterms:abstract>
   <dcterms:issued>2020-11-02T09:44:09Z</dcterms:issued>
   <dcterms:issued>2020-11-02T09:44:09Z</dcterms:issued>
   <dcterms:issued>2012-04-01</dcterms:issued>
   <dcterms:issued>2020-10-29T15:04:25Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:relation>Versió postprint del document publicat a: https://doi.org/10.1038/484044a</dc:relation>
   <dc:relation>Nature, 2012, vol. 484, issue. 7392, p. 44-46</dc:relation>
   <dc:relation>https://doi.org/10.1038/484044a</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/EC/FP7/281830/EU//STROMALIGN</dc:relation>
   <dc:rights>(c) Springer Science and Business Media LLC, 2012</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Springer Science and Business Media LLC</dc:publisher>
   <dc:source>Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>